FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2708792145> ?p ?o ?g. }

• W2708792145 endingPage "701" @default.
• W2708792145 startingPage "695" @default.
• W2708792145 abstract "It is essential that patients undergoing carotid artery stenting (CAS) receive optimal antiplatelet inhibition. Although a reduction in platelet reactivity and improved clinical outcomes occur when using adjunctive cilostazol with dual antiplatelet therapy, this can lead to an increased risk of hemorrhagic complications. Therefore, our current study examined patients undergoing CAS and evaluated the impact of cilostazol-based dual antiplatelet treatment on the outcomes.Between 2010 and 2015, 137 consecutive patients underwent CAS. From 2010 to 2011 (period 1), 28 patients underwent CAS in conjunction with aspirin and clopidogrel dual antiplatelet treatment (DAPT). From 2010 to 2013 (period 2), 44 patients underwent a preoperative assessment of their platelet function, with the clopidogrel-resistant patients receiving adjunctive cilostazol in addition to the aspirin and clopidogrel. From 2013 to 2015 (period 3), 65 patients underwent CAS in conjunction with cilostazol and clopidogrel treatment. In all patients, the incidence of new ipsilateral ischemic lesions observed by diffusion-weighted imaging on the day after CAS, and ischemic or hemorrhagic events occurring within 30 days were assessed.Clopidogrel resistance was identified in 43% of the patients in period 1, in 16% in period 2, and in 5% in period 3 (P < 0.001). The on-treatment platelet reactivity results indicated that the PRU value during cilostazol-based DAPT was significantly lower than that observed for the standard DAPT (P < 0.05). New ipsilateral ischemic lesions decreased by 9% and 8% in periods 2 and 3, respectively, versus a 25% decrease in period 1 (P = 0.047). However, there were no significant differences noted for any of the hemorrhagic or thromboembolic events.Compared to the standard aspirin and clopidogrel dual antiplatelet therapy, cilostazol-based dual antiplatelet treatment reduces the rate of clopidogrel resistance and suppresses new ischemic lesions without hemorrhagic complications." @default.
• W2708792145 created "2017-06-30" @default.
• W2708792145 creator A5002830709 @default.
• W2708792145 creator A5002954243 @default.
• W2708792145 creator A5018526643 @default.
• W2708792145 creator A5029714930 @default.
• W2708792145 creator A5060268134 @default.
• W2708792145 creator A5078888657 @default.
• W2708792145 creator A5079016992 @default.
• W2708792145 creator A5084912887 @default.
• W2708792145 date "2017-03-14" @default.
• W2708792145 modified "2023-09-26" @default.
• W2708792145 title "Efficacy of cilostazol-based dual antiplatelet treatment in patients undergoing carotid artery stenting" @default.
• W2708792145 cites W168371622 @default.
• W2708792145 cites W18470154 @default.
• W2708792145 cites W1965802560 @default.
• W2708792145 cites W1974655135 @default.
• W2708792145 cites W1983893864 @default.
• W2708792145 cites W2001759058 @default.
• W2708792145 cites W2007242643 @default.
• W2708792145 cites W2014459583 @default.
• W2708792145 cites W2015521606 @default.
• W2708792145 cites W2017801694 @default.
• W2708792145 cites W2038169486 @default.
• W2708792145 cites W2049913259 @default.
• W2708792145 cites W2050306424 @default.
• W2708792145 cites W2068804349 @default.
• W2708792145 cites W2085817407 @default.
• W2708792145 cites W2100194095 @default.
• W2708792145 cites W2101924617 @default.
• W2708792145 cites W2105489963 @default.
• W2708792145 cites W2115774068 @default.
• W2708792145 cites W2129794503 @default.
• W2708792145 cites W2144194629 @default.
• W2708792145 cites W2145425156 @default.
• W2708792145 cites W2148944238 @default.
• W2708792145 cites W2161785946 @default.
• W2708792145 cites W2317492427 @default.
• W2708792145 cites W27443843 @default.
• W2708792145 doi "https://doi.org/10.1080/01616412.2017.1301042" @default.
• W2708792145 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28290236" @default.
• W2708792145 hasPublicationYear "2017" @default.
• W2708792145 type Work @default.
• W2708792145 sameAs 2708792145 @default.
• W2708792145 citedByCount "11" @default.
• W2708792145 countsByYear W27087921452017 @default.
• W2708792145 countsByYear W27087921452018 @default.
• W2708792145 countsByYear W27087921452019 @default.
• W2708792145 countsByYear W27087921452021 @default.
• W2708792145 countsByYear W27087921452022 @default.
• W2708792145 countsByYear W27087921452023 @default.
• W2708792145 crossrefType "journal-article" @default.
• W2708792145 hasAuthorship W2708792145A5002830709 @default.
• W2708792145 hasAuthorship W2708792145A5002954243 @default.
• W2708792145 hasAuthorship W2708792145A5018526643 @default.
• W2708792145 hasAuthorship W2708792145A5029714930 @default.
• W2708792145 hasAuthorship W2708792145A5060268134 @default.
• W2708792145 hasAuthorship W2708792145A5078888657 @default.
• W2708792145 hasAuthorship W2708792145A5079016992 @default.
• W2708792145 hasAuthorship W2708792145A5084912887 @default.
• W2708792145 hasConcept C126322002 @default.
• W2708792145 hasConcept C164705383 @default.
• W2708792145 hasConcept C2777628954 @default.
• W2708792145 hasConcept C2777849778 @default.
• W2708792145 hasConcept C2778905298 @default.
• W2708792145 hasConcept C2779169563 @default.
• W2708792145 hasConcept C2779820409 @default.
• W2708792145 hasConcept C2781068581 @default.
• W2708792145 hasConcept C2987047532 @default.
• W2708792145 hasConcept C42219234 @default.
• W2708792145 hasConcept C71924100 @default.
• W2708792145 hasConceptScore W2708792145C126322002 @default.
• W2708792145 hasConceptScore W2708792145C164705383 @default.
• W2708792145 hasConceptScore W2708792145C2777628954 @default.
• W2708792145 hasConceptScore W2708792145C2777849778 @default.
• W2708792145 hasConceptScore W2708792145C2778905298 @default.
• W2708792145 hasConceptScore W2708792145C2779169563 @default.
• W2708792145 hasConceptScore W2708792145C2779820409 @default.
• W2708792145 hasConceptScore W2708792145C2781068581 @default.
• W2708792145 hasConceptScore W2708792145C2987047532 @default.
• W2708792145 hasConceptScore W2708792145C42219234 @default.
• W2708792145 hasConceptScore W2708792145C71924100 @default.
• W2708792145 hasIssue "8" @default.
• W2708792145 hasLocation W27087921451 @default.
• W2708792145 hasLocation W27087921452 @default.
• W2708792145 hasOpenAccess W2708792145 @default.
• W2708792145 hasPrimaryLocation W27087921451 @default.
• W2708792145 hasRelatedWork W1752023873 @default.
• W2708792145 hasRelatedWork W2016341115 @default.
• W2708792145 hasRelatedWork W2032205507 @default.
• W2708792145 hasRelatedWork W2034438272 @default.
• W2708792145 hasRelatedWork W2171794591 @default.
• W2708792145 hasRelatedWork W2393299562 @default.
• W2708792145 hasRelatedWork W2417919531 @default.
• W2708792145 hasRelatedWork W3157179403 @default.
• W2708792145 hasRelatedWork W3193365717 @default.
• W2708792145 hasRelatedWork W3195461853 @default.
• W2708792145 hasVolume "39" @default.

• next